Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Cholesterol | HCID 5997 | — |
| Reactant | HCID 18664939 | HCID 18664939 | — |
| Catalyst | Silver(I) trifluoromethanesulfonate | HCID 76223 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | HCID 86607619 | HCID 86607619 | — |
Reaction Steps
Compound 4 (see FIG. 12) was prepared from galactose 1 that was treated with pivaloyl chloride in pyridine. Instead of the expected penta-pivaloyl derivative, the partially pivaloylated compound 2 was obtained in good yield and high purity without the need of chromatographic purification. The free hydroxyl group in compound 2 was protected by an acetyl group (→3). This was followed by treatment with hydrogen bromide in acetic acid to provide the galactosyl bromide 4. Bromide 4 was coupled with cholesterol 5 under promotion by silver trifluoromethanesulfonate in dichloromethane to provide the desired β-galactosyl-cholesterol 6 in a stereoselective manner (see FIG. 13). The β-anomeric configuration was demonstrated by 1-H NMR spectroscopy. The O-protecting groups were subsequently removed by treatment with sodium methoxide in a mixture of anhydrous dichloromethane and methanol to provide the cholesteryl β-D-galactopyranoside 7 as an amorphous solid.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07666846B2 |
|---|
| Source dataset | uspto-grants-2010_02 |
|---|
| ORD ID | ord-bc06666b6d644ce0bec31279f27044f4 |
|---|
| Source note | uspto-grants-2010_02 |
|---|